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In Brief
The correct ratio of HIV-1 Gag to envelope
(Env) is important for virion infectivity. Mu
et al. demonstrate that host factor RVB2
inhibits Gag protein expression but is
antagonized by Env and that HIV-1 uses
this mechanism to balance the relative
expression of Gag and Env for virion
production.
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The correct ratio of the HIV-1 structural protein Gag
to the envelope protein (Env) is important for
maximal virion infectivity. How the virus ensures
the production of Gag and Env proteins in an appro-
priate ratio remains unknown. We report that HIV-1
exploits the host factor RuvB-like 2 (RVB2) to bal-
ance relative expression of Gag and Env for efficient
production of infectious virions. RVB2 inhibits Gag
expression by interacting with both the encodedMa-
trix (MA) domain of Gag protein and 50 UTR of the
translating mRNA and promoting mRNA degradation
in a translation-dependent manner. This inhibitory
activity of RVB2 is antagonized by Env through
competitive interaction with MA, allowing Gag syn-
thesis to proceed when Env levels are adequate for
virion assembly. In HIV-1-positive patients, RVB2
levels positively correlate with viral loads and dis-
ease progression status. These findings reveal a
mechanism by which HIV-1 regulates its protein
expression.
INTRODUCTION
The virion particles of the human immunodeficiency virus type 1
(HIV-1) encapsidate the RNA genome in a core particle formed
from the Gag proteins, surrounded by a membrane bilayer con-
taining the viral envelope (Env) protein. Gag is synthesized as a
polyprotein from the unspliced viral RNA and cleaved into indi-
vidual structural proteins by the viral encoded protease,
including Matrix (MA), Capsid (CA), Nucleocapsid (NC) and a
protein of 6 kDa (p6), during virion maturation (Sundquist and
Kra¨usslich, 2012). Env is translated from a singly spliced
mRNA as a polyprotein. With an endoplasmic reticulum (ER)
localization signal at the N terminus, Env translocates into ER
during its synthesis. The complete translocation of Env into ER
is prevented by a hydrophobic transmembrane domain, leaving
the C-terminal domain (CTD) exposed in the cytoplasm. Env pro-
teins form trimers in ER and are cleaved into the surface protein
(gp120) and the transmembrane protein (gp41) in Golgi (Check-
ley et al., 2011).Cell HosResults fromprevious studies suggest that at the early stage of
viral gene expression, Gag expression precedes or coincides
with Env expression (Guatelli et al., 1990; Mohammadi et al.,
2013). Gag alone is able to form noninfectious ‘‘bald’’ particles
on the plasma membrane and bud from the producer cells
(Gheysen et al., 1989). When Env is present on the membrane,
the particles formed from Gag carry the membrane together
with Env to form infectious particles. There are several lines of
evidence indicating that the interaction between MA and Env
CTD is important for the incorporation of Env into viral particles,
although debates exist with respect to the necessity of this inter-
action (Tedbury and Freed, 2014). How the virus ensures a cor-
rect number of Env molecules to be incorporated into the virions
is not clear.
RVB2 is a member of the AAA+ (ATPases associated with a
variety of cellular activities) superfamily and is ubiquitously ex-
pressed (Nano and Houry, 2013). RVB2 and its homolog RuvB-
like 1 (RVB1) can form a complex, which has been reported to
participate in a variety of biological processes, such as transcrip-
tion, DNA repair, and telomerase complex assembly (Nano and
Houry, 2013). They also participate in the nonsense-mediated
mRNA decay through interactions with SMG-1 and the mRNP,
suggesting a role of RVB1/RVB2 in mRNA metabolism (Izumi
et al., 2010). There are several lines of evidence showing that
RVB2 also functions independently of RVB1 (Diop et al., 2008;
Kakugawa et al., 2009). For example, RVB2 inhibits influenza A
virus replication in an RVB1-independent manner by interfering
with the oligomerization of the viral nucleoproteins (Kakugawa
et al., 2009). A recent study showed that RVB2 is a key regulator
in humoral immunity, essential for T cell development and
maximal T cell-dependent antibody responses (Arnold et al.,
2012).
Here, we show that RVB2 inhibits HIV-1 Gag expression and
that this inhibitory activity is antagonized by the viral Env. We
provide evidence indicating that the interactions between
RVB2 and the viral proteins balance their relative expression
levels for efficient production of infectious virion particles.RESULTS
RVB2 Inhibits VSV-G Pseudotyped HIV-1 Vector
Production
Given the important roles MA plays in the life cycle of HIV-1
(Hearps and Jans, 2007), we set out to identify MA-interactingt & Microbe 18, 233–242, August 12, 2015 ª2015 Elsevier Inc. 233
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Figure 1. RVB2 Inhibits VSV-G Pseudotyped HIV-1 Vector Produc-
tion through Inhibiting Gag Expression
(A and B) VSV-G pseudotyped HIV-1 vector-producing plasmids were trans-
fected into HEK293 cells together with an indicated plasmid. A plasmid ex-
pressing renilla luciferase, which is not responsive to RVB2, was included to
serve as a control for transfection efficiency and sample handling. A fraction of
the culture supernatant was used to infect recipient cells, and the rest was
concentrated by ultracentrifugation for p24 levels measurement by western
blotting (upper panel). At 48 hr postinfection, firefly luciferase activity was
measured in the recipient cells and normalized by the renilla luciferase activity
in the producer cells (lower panel). Relative luciferase activity in the recipient
cells infected with the virus produced from empty vector-transfected cells was
set as 1. Data presented are means ± SD of three independent experiments.
Ctrli, control shRNA; R2i, shRNA targeting RVB2; Rm, a rescue RVB2-ex-
pressing plasmid that is not targeted by R2i.
(C and D) HIV-1 vector-producing plasmids indicated were transfected into
HEK293 cells together with a plasmid indicated. A plasmid expressing myc-
tagged GFP was included to serve as a control. At 48 hr posttransfection, cells
were lysed and analyzed for protein levels by western blotting.
The band intensities of p24, p55, and GFP were measured using Image J
software. The intensity of p55 in the cell lysate was normalized with that of
GFP. The relative intensity of p55 or p24 in the control cells was set as 1. Data
presented are means ± SD of three independent experiments. See also
Figures S1–S4.proteins as host factors potentially involved in HIV-1 replication.
MA was fused at the C terminus with a tandem affinity purifica-
tion (TAP) tag and expressed in a tetracycline-inducible manner234 Cell Host & Microbe 18, 233–242, August 12, 2015 ª2015 Elseviin 293TRex cells. MA-TAP and associated proteins were sub-
jected to electrophoresis on SDS-PAGE. A protein of about
50 kDa that specifically bound to MA-TAP but not to TAP alone
was analyzed by MALDI-TOF and identified as RuvB-like 2
(RVB2) (see Figure S1A available online). The interaction be-
tween RVB2 and MA was confirmed by coimmunoprecipitation
assays (Figure S1B).
To probe the function of RVB2 in HIV-1 replication, we first
analyzed whether overexpression of RVB2 affects the produc-
tion of vesicular stomatitis virus G (VSV-G)-pseudotyped HIV-1
vector NL4-3luc, in which an engineered stop codon abolishes
Env expression and a luciferase reporter is inserted into the
coding sequence of Nef (Connor et al., 1995). The pseudovirus
was produced in HEK293 cells with or without the expression
of Flag-tagged RVB2, and the released virion particles were
used to infect recipient HeLa cells. Data showed that overex-
pression of RVB2 reduced CA (p24) levels in culture superna-
tants in a dose-dependent manner (Figure 1A, upper panel).
Consistently, the luciferase activity in the recipient cells ex-
pressed from the virus was reduced by RVB2 overexpression
(Figure 1A, lower panel). To test the function of endogenous
RVB2, an shRNA targeting RVB2 was designed and confirmed
for its ability to downregulate RVB2 expression (Figure S2A).
Indeed, downregulation of endogenous RVB2 in HEK293 cells
increased CA levels in culture supernatants and luciferase activ-
ity in the virus-infected recipient cells (Figure 1B). When MT-4
cells, a CD4+ T cell line that effectively support HIV-1 replication,
were transfected with plasmids to produce VSV-G pseudotyped
NL4-3luc, downregulation of endogenous RVB2 also increased
the virus production (Figure S2B). Notably, the viral protein
expression levels in the transfected cells were within the range
of those in HIV-1-infectedMT4 cells (Figure S2C). HIV-1 infection
of MT4 cells did not obviously affect the expression levels of
RVB2 (Figure S2C). Taken together, these results indicate that
RVB2 at its endogenous levels and upon overexpression inhibits
the production of VSV-G pseudotyped NL4-3luc virus. In
addition, RVB2 expression also inhibited VSV-G pseudotyped
HIV-2 and SIVmac virus vectors (Figure S3).
RVB2 Inhibits GagExpression in aMannerDependent on
Its Interaction with MA
We next analyzed transfected producer cells for the protein
levels of Gag (p55). Data showed that overexpression of RVB2
reduced the levels of Gag expressed from NL4-3luc genome
(Figure 1C), and downregulation of endogenous RVB2 increased
Gag levels in the producer cells (Figure 1D). In consideration of
the fact that in many cases RVB2 functions in complex with
RVB1, we tested whether RVB1 inhibits Gag expression. In
contrast to RVB2, overexpression of RVB1 had little effect on
Gag levels, and downregulation of endogenous RVB1 failed to
increase Gag levels (Figure S4). These results indicate that
RVB2, but not RVB1, acts to reduce production of VSV-G pseu-
dotyped NL4-3luc by reducing Gag levels in the producer cells.
To understand how RVB2 expression reduces Gag levels, the
coding sequence of Gag was cloned into a mammalian expres-
sion vector with or without the 50 untranslated region (UTR), both
under the transcriptional control of the CMV promoter (Fig-
ure 2A). The resulting constructs, referred to as pUTRGag and
pGag, respectively, were tested for their sensitivity to RVB2.er Inc.
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Figure 2. The 50 UTR of gag mRNA and Cod-
ing Sequence of MA Are Required for RVB2
to Inhibit Gag Expression
(A) Schematic representation of Gag expression
constructs. The fork before the coding sequence of
MA represents a point mutation in the start codon.
The arrow represents an engineered translation start
codon. SL, stem-loop region.
(B and C) The indicated Gag-expressing plasmids
were transfected into HeLa cells together with a
plasmid expressing RVB2. A plasmid expressing
GFP was included to serve as a control. Gag
expression was detected by western blotting.
(D) Flag-tagged RVB2 and firefly luciferase re-
porters indicated were separately expressed in
HEK293T cells. The cell lysates were mixed and
RVB2 was immunoprecipitated. Firefly luciferase
activity was measured in the total lysates and
precipitates. Relative interactions between RVB2
and luciferase reporters were calculated as the
firefly luciferase activity in the precipitates divided
by that in the total lysates. The relative interaction
in the absence of RVB2 was set as 1. Data pre-
sented are means ± SD of three independent
experiments.
(E) Firefly luciferase reporters indicated were trans-
fected into HeLa cells together with an empty vector
or a plasmid expressing Flag-tagged RVB2. A
plasmid expressing renilla luciferase was included
to serve as a control. Firefly luciferase activity
was normalized by the renilla luciferase activity.
Fold inhibition was calculated as the normalized
luciferase activity in the absence of RVB2 divided by that in the presence of RVB2. Data presented are means ± SD of three independent experiments.
The band intensities of Gag proteins and GFP were measured using Image J software. The intensities of Gag proteins were normalized with those of GFP. The
relative intensity of Gag proteins in the control cells was set as 1. Data presented are means ± SD of three independent experiments.The Gag protein levels expressed from these constructs were
generally lower than those expressed from NL4-3luc (data not
shown), likely due to the lack of RRE in these constructs. Data
showed that the levels of Gag expressed from pUTRGag were
reduced by RVB2 (Figure 2B). However, the levels of Gag ex-
pressed from pGag were little affected (Figure 2B). These results
suggest that the 50 UTR is required for RVB2 inhibition of Gag
expression and that RVB2 inhibits Gag expression without
directly affecting the protein once it is synthesized. The 50 UTR
is composed of sequences dubbed R, U5, the primer binding
site, and three putative stem-loop structures (referred to as the
SL region) (Ramezani and Hawley, 2002). Deletion of a fragment
up to the SL region had little effect on RVB2 inhibition of Gag
expression (Figures 2A and 2B). These results indicate that the
SL region in the 50 UTR is required for RVB2 inhibition of Gag
expression.
Given the known interaction between RVB2 andMA, we inves-
tigated the role of MA in RVB2 inhibition of Gag expression. The
coding sequence of MAwas deleted (DMA), or the start codon of
MA [()MA] was mutated and an ectopic start codon was engi-
neered upstream of the coding sequence of CA (Figure 2A). In
contrast to the Gag expression from pUTRGag, protein expres-
sion from these constructswasnot inhibited byRVB2 (Figure 2C).
Furthermore, a reporter containing only the SL region and the
coding sequence of MA was sufficient to be responsive to
RVB2 (Figure 2B). These results indicate that both the 50 UTR
and MA expression are required for RVB2 inhibition.Cell HosTo develop amore quantitative assay to evaluate the inhibitory
effect of RVB2 and to probe the relationship between MA
interaction with RVB2 and its sensitivity to RVB2, a luciferase re-
porter was constructed, wherein the SL region and the coding
sequence of MA were fused in frame with that of firefly luciferase
(SLMA-luc). The reporter and RVB2 were separately expressed
in HEK293T cells. The cell lysates were mixed, RVB2 was immu-
noprecipitated, and the luciferase activity in the precipitates
reflects MA interaction with RVB2. Using this assay, MA se-
quences from different HIV-1 subtypes were screened for an
RVB2 interaction variant. The MA from group O (O pCMO2.5,
hereafter referred to as OCM) displayed little interaction, while
the MA from group N (N 02CM SJGddd, hereafter referred to
as N02) interacted with RVB2 almost as well as the MA from
NL4-3 (Figure 2D). These reporters were analyzed for their sensi-
tivity to RVB2. Data showed that RVB2 significantly inhibits the
expression of the reporter containing the MA from NL4-3 and
N02 (Figure 2E). In contrast, RVB2 had little effect on the reporter
containing the MA from OCM (Figure 2E). These results indicate
that interaction of MA with RVB2 is required for RVB2 to inhibit
MA expression.
RVB2 Interacts with Target mRNA in a
Translation-Dependent Manner
In order to investigate why both the SL region andMA interaction
are required for RVB2 to inhibit reporter expression, we asked
whether RVB2 interacts with the translating mRNA and whethert & Microbe 18, 233–242, August 12, 2015 ª2015 Elsevier Inc. 235
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Figure 3. RVB2 Interacts with Target mRNA in an MA Translation-
Dependent Manner
(A and B) Firefly luciferase reporters indicated were transiently expressed in
HeLa cells with or without Flag-tagged RVB2. RVB2 was immunoprecipitated
and detected by western blotting. The reporter mRNA in the lysates (input) and
in the precipitates (IP) was detected by reverse-transcription PCR. (B) Cells
were mock treated or treated with cycloheximide (CHX) for 6 hr to block global
translation. + RT, RNA was reverse transcribed;RT, no reverse transcriptase
was added.the interaction requires MA expression. To serve as negative
controls, reporters SL()MA-luc and SL-luc were constructed,
wherein the coding sequence of firefly luciferase was cloned
downstream of SL()MA [SL()MA-luc ] or downstream of the
SL region (SL-luc), respectively. The reporters were coex-
pressed with Flag-tagged RVB2, and RVB2 protein was immu-
noprecipitated and the associated RNA was detected by
reverse-transcription PCR. Data showed that the mRNA of
SLMA-luc coprecipitated with RVB2 (Figure 3A). In contrast,
the mRNA of SL()MA-luc or SL-luc failed to do so (Figure 3A).
These results suggest that RVB2 interacts with target mRNA in
a manner dependent on the translation of MA. To substantiate
this notion further, the interaction between RVB2 and SLMA-
luc mRNA was assayed in cells treated with cycloheximide
(CHX), which blocks global translation. Indeed, treatment with
CHX abolished the interaction between RVB2 and target
mRNA (Figure 3B). Notably, these results also revealed that
RVB2 reduced the mRNA level of SLMA-luc but not that of the
nonresponsive reporters, and this reduction in the target
mRNA level was removed by blocking translation (Figure 3B,
reporter RNA input panel).
RVB2 Promotes Target mRNA Decay in a
Translation-Dependent Manner
We next analyzed the effect of RVB2 on the levels of target
mRNA. NL4-3luc was expressed with or without RVB2, and
gag mRNA levels were determined by reverse-transcription
PCR. Data showed that RVB2 significantly reduced gag mRNA
levels in the cytoplasm with little effect on the mRNA levels in
the nucleus (Figure 4A). In contrast, RVB2 barely affected nef-
luc,vif or env mRNA levels (Figure 4A) in the cytoplasm or nu-
cleus. Similar results were obtained when the samples were
analyzedwith quantitative reverse-transcription PCR (Figure 4B).
These results suggest that RVB2 does not affect the transcrip-
tion of the viral mRNA but instead specifically promotes target
mRNA degradation in the cytoplasm. To further support this
notion, we measured the decay rates of gag mRNA in the cyto-
plasm with or without RVB2. Data showed that RVB2 signifi-236 Cell Host & Microbe 18, 233–242, August 12, 2015 ª2015 Elsevicantly increased the decay rate of gag mRNA (Figure 4C). In
contrast, RVB2 overexpression had little effect on the decay
rate of nef-luc, vif, env, or cellular gapdh mRNA (Figure 4C). In
line with the above results (Figure 3B), blocking translation pro-
tected target viral mRNA from RVB2-mediated degradation (Fig-
ure 4D). Collectively, these results indicate that RVB2 promotes
target mRNA decay in the cytoplasm using a mechanism depen-
dent on the translation of MA.
RVB2 Associates with Ribosomes, and Downregulation
of Pelo Prevents RVB2-Mediated Target mRNA
Degradation
We next investigated the mechanism by which RVB2 promotes
target mRNA degradation. We hypothesized that simultaneous
binding of RVB2 to nascent MA and the translating mRNA might
cause ribosome stalling and subsequent degradation of target
mRNA, which was conceptually similar to no-go decay (NGD)
in mRNA surveillance (Graille and Se´raphin, 2012). It is known
that stalling ribosomes recruit Pelo and Hbs1L to initiate target
mRNA degradation (Becker et al., 2011; Graille and Se´raphin,
2012). Our hypothesis predicted that (1) RVB2 should associate
with ribosomes, probably in a target mRNA-dependent manner;
and (2) downregulation of Pelo or Hbs1L should reduce target
mRNA degradation to some extent. To test this hypothesis, we
first analyzed whether RVB2 associates with ribosomes. Three
reporters were used: SLMA-luc, MA-luc, and SL-luc. Consistent
with the foregoing results, RVB2 specifically inhibited the
expression of SLMA-luc but not MA-luc or SL-luc (Figure 5A). Ri-
bosomes in the lysates of the cells expressing RVB2 and these
reporters were pelleted through sucrose cushion, the associated
proteins were detected by western blotting, and the associated
RNAs were detected by reverse-transcription PCR. RVB2 was
easily detected in the ribosome pellet in the presence of the
RVB2-responsive reporter SLMA-luc (Figure 5B). In comparison,
in the presence of MA-luc, which is barely responsive to RVB2
(Figure 5A), the level of ribosome-associated RVB2 was consid-
erably reduced (Figure 5B). In the presence of the control
reporter SL-luc, very little RVB2 was detected in the ribosome
pellet (Figure 5B). All the reporter mRNAs were detected in the
ribosome pellet (Figure 5B). These results indicate that RVB2
indeed associates with ribosomes in a reporter mRNA-depen-
dent manner.
To further test our hypothesis, Pelo was downregulated by an
siRNA, and the effect on RVB2-mediated target mRNA degrada-
tion of SLMA-luc was evaluated. The siRNA targeting Pelo
effectively downregulated the mRNA level of endogenous Pelo
(Figure 5C). Downregulation of endogenous Pelo did not affect
RVB2 inhibition of SLMA-luc protein expression (Figure 5D).
However, downregulation of Pelo almost prevented RVB2-medi-
ated slma-lucmRNA degradation (Figure 5E). These results sup-
port our hypothesis that RVB2 induces ribosome stalling and the
following target mRNA degradation.
RVB2 Is Antagonized by HIV-1 Env
The inhibitory effects of RVB2 on Gag expression described
above were detected using HIV-1 vector NL4-3luc. We next
analyzed the effect of RVB2 on the replication-competent virus
NLenv-luc. In contrast to NL4-3luc, Gag expression from
NLenv-lucwas little affected byRVB2 overexpression (Figure 6A)er Inc.
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Figure 4. RVB2 Promotes Target mRNA
Degradation in a Translation-Dependent
Manner
(A–C) pNL4-3luc was transfected into HeLa cells
with or without a plasmid expressing RVB2. (A) At
48 hr posttransfection, nuclear and cytoplasmic
RNA was extracted and detected by reverse-
transcription PCR. (B) At 48 hr posttransfection,
cytoplasmic RNA was extracted and detected
by real-time PCR. The viral mRNA levels were
normalized by gapdh mRNA levels. The normal-
ized mRNA levels in empty vector-transfected
cells were set as 1. (C) At 36 hr posttransfection,
cells were treated with actinomycin D (act.D) to
stop global transcription. Cytoplasmic RNA was
extracted at the time points indicated and quanti-
fied by real-time PCR. The mRNA level in the cells
without actinomycin D treatment was set as 1.
Data presented in (B) are means of ± SD of two
independent measurements, representative of two
independent experiments. Data presented in (C)
are means ± SEM of two independent measure-
ments, representative of two independent experi-
ments. EV, empty vector.
(D) Gag-expressing plasmids indicated were
transfected into HeLa cells with or without
a plasmid expressing RVB2. At 40 hr post-
transfection, cells were mock treated or treated
with CHX. At 4 hr thereafter, RNA levels were
analyzed.or by downregulation of endogenous RVB2 (Figure 6B). Since the
only difference between NLenv-luc and NL4-3luc is that NLenv-
luc expresses a functional full-length Env, which is absent in
NL4-3luc, we reasoned that the activity of RVB2 might be antag-
onized by Env. Indeed, coexpression of HIV-1 Env relieved the
inhibitory effect of RVB2 on Gag expression from NL4-3luc (Fig-
ures 6C and 6D).
The full-length HIV-1 Env is synthesized in the ER and trans-
ported onto the plasma membrane. Thus, only the C terminus
of Env is expected to be accessible to Gag, which is synthesized
in the cytosol. In addition, a fragment of the CTD of HIV-1 Env,
derived from proteolytic cleavage of the protein or from alterna-
tive splicing of the Env-encoding mRNA, was recently identified
in HIV-1-infected or HIV-1 vector-transfected cells (Pfeiffer et al.,
2013). We thus reasoned that this CTD might be a functional
RVB2-antagonizing domain. Indeed, expression of Env CTD
alone relieved the inhibitory effect of RVB2 on Gag expression
(Figure 6E).
It is well established that HIV-1 Env CTD interacts with MA
(Checkley et al., 2011). Since the interaction between RVB2
andMA is required for RVB2 inhibition of Gag expression, we hy-
pothesized that Env CTD might antagonize RVB2 by competi-
tively interacting with MA. The sequences of HIV-1 Env CTDs
from different subtypes differ considerably (Buonaguro et al.,
2007). We first screened Env CTDs from different subtypes ofCell Host & Microbe 18, 233–242HIV-1 for the loss of interaction with
NL4-3 MA, and the Env CTD from the
N02 subtype was identified as a nonin-
teracting variant (Figure 6F). We then
analyzed whether various Env CTDs caninhibit the interaction between RVB2 and MA. The proteins
were coexpressed in HEK293 cells, and the interactions were
analyzed by coimmunoprecipitation assays. In the absence of
Env CTD, immunoprecipitation of MA coprecipitated RVB2
efficiently (Figure 6G). When the Env CTD from NL4-3 was coex-
pressed with MA and RVB2, immunoprecipitation of MA copre-
cipitated only Env CTD but not RVB2 (Figure 6G). In contrast,
when the Env CTD fromN02was coexpressed, it failed to disrupt
the interaction between MA and RVB2 (Figure 6G). These results
strongly suggest that the Env CTD from NL4-3 antagonizes
RVB2 inhibition of Gag expression through competitively inter-
acting with MA. To further support this notion, the Env CTD in
NLenv-luc was replaced with that from N02 (NLN02-luc). The
production of the chimeric virus was considerably reduced (Fig-
ure S5A) and was now significantly enhanced by downregulation
of endogenous RVB2, whereas the production of NLenv-luc was
little affected (Figure S5B). In line with these results, Gag and CA
levels expressed from NLN02-luc were enhanced by downregu-
lation of RVB2, whereas those expressed from NLenv-luc were
little affected (Figure 6H).
RVB2 Modulates HIV-1 Infectivity at an Early Stage of
Virus Production
We next analyzed the effect of RVB2 inhibition of Gag expres-
sion and the antagonism of the inhibition by Env on the infectivity, August 12, 2015 ª2015 Elsevier Inc. 237
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Figure 5. Downregulation of Pelo Prevents
RVB2-Mediated Target mRNA Degradation
(A and B) Firefly luciferase reporters indicated were
transiently transfected into HeLa cells with or
without a plasmid expressing Flag-tagged RVB2. A
plasmid expressing renilla luciferase was included
to serve as a control. (A) A fraction of the cell lysate
was used to measure luciferase activities. Firefly
luciferase activity was normalized by renilla lucif-
erase activity. Fold inhibition was calculated as the
normalized luciferase activity in the absence of
RVB2 divided by that in the presence of RVB2. Data
presented are means of ± SD of two independent
measurements, representative of two independent
experiments. (B) The rest of the cell lysate was pu-
rified through sucrose cushion to pellet ribosomes.
The pellets were analyzed for protein levels by
western blotting and for RNA levels by reverse-
transcription PCR. S16 is a component of the 40S
ribosome subunit.
(C) An siRNA targeting Pelo was transiently trans-
fected into HeLa cells. At 48 hr posttransfection,
cytoplasmic RNA was extracted and mRNA levels
were analyzed by real-time PCR. The levels of
pelo mRNA were normalized by the levels of
gapdh mRNA. The normalized mRNA level in
control siRNA-transfected cells was set as 1. Data
presented aremeans ± SD of two independentmeasurements, representative of three independent experiments. Ctrli, control siRNA; Peloi, siRNA targeting Pelo.
(D and E) The firefly luciferase reporter indicated was transiently expressed in HeLa cells with a control siRNA or an siRNA targeting Pelo (Peloi), with or without
Flag-tagged RVB2. A plasmid expressing renilla luciferase was included to serve as a control. At 48 hr posttransfection, luciferase activities were measured (D)
and mRNA levels of the reporter were measured by real-time PCR (E). Reporter luciferase activity was calculated as firefly luciferase activity divided by renilla
luciferase activity. The normalized luciferase activity in the cells transfected with the empty vector and control siRNA was set as 1. The levels of slma-lucmRNA
were normalized by the levels of renilla mRNA. The normalized mRNA in the cells transfected with the empty vector and control siRNA was set as 1. Data
presented are means ± SD of two independent measurements, representative of three independent experiments.of the produced virus. An optimally infectious HIV-1 virion parti-
cle requires proper amounts of Gag and Env, which are ex-
pressed from two different species of mRNAs. It has been
reported that Gag expression precedes or coincides with Env
expression (Guatelli et al., 1990; Mohammadi et al., 2013). We
reasoned that in the absence of enough Env, robust Gag expres-
sion would lead to the production of noninfectious ‘‘bald’’
virions, and RVB2 inhibition of Gag expression and the antago-
nism of RVB2 by Env would help to balance the relative expres-
sion levels of Gag versus Env. To test this hypothesis, we
analyzed the effect of downregulating endogenous RVB2 on
the production of infectious virions. The virus producing plasmid
pNL4-3 was transfected into HEK293T cells with or without
an shRNA targeting RVB2. The expression levels of both Gag
and Env increased over time posttransfection (Figure 7A). At
12 hr posttransfection, when Env was expressed at a low level,
downregulation of RVB2 increased Gag levels but had little
effect on Env expression (Figure 7A). The concentrations of
the virions in the culture supernatants were so low that they
could be detected only after concentration by centrifugation.
In agreement with the increased Gag levels in the producer cells,
downregulation of RVB2 increased virion-associated CA levels
(Figure 7B). However, at 24 hr posttransfection, when Env was
expressed at a higher level, downregulation of RVB2 had little
effect on Gag levels in the producer cells (Figure 7A) or on the
virion-associated CA levels in the culture supernatants (Fig-
ure 7B). To measure the infectivity of the produced virus, equal
amounts of the virus, as measured by the CA levels, were used238 Cell Host & Microbe 18, 233–242, August 12, 2015 ª2015 Elsevito infect TZM-bl indicator cells (Da et al., 2011). In these cells
the expression level of a luciferase reporter is proportionally
dependent on the amount of incoming infectious virus, thereby
reflecting the infectivity of the virus. At 12 hr posttransfection,
downregulation of RVB2 significantly reduced the infectivity of
the produced virus (Figure 7C). In comparison, at 24 hr post-
transfection, downregulation of RVB2 had little effect (Figure 7C).
These results support the notion that at an early stage of virion
production HIV-1 uses RVB2 to balance viral Gag and Env
expression for efficient production of infectious virions. As
a proof of concept, these experiments were performed in
HEK293T cells. We performed similar experiments using CD4+
T cells, but the titer of the produced virus was too low to be
detected at an early time posttransfection.
It is conceivable that in vivo, without RVB2, production of
noninfectious bald virions would alert the immune system
before infectious virus is produced and thus viral replication
would be better controlled by the host. To test this idea, we
analyzed RVB2 mRNA levels in HIV-1-positive patients who
were divided into two groups: rapid progressors (RPs) and
long-term nonprogressors (LTNPs) (see Supplemental Informa-
tion for more information on the patients). Data showed that
the average RVB2 mRNA levels in LTNPs were significantly
lower than those in RPs (Figure 7D). Furthermore, RVB2 levels
positively correlated with the viral loads (Figure 7E) and
inversely correlated with CD4+ T cell numbers (Figure 7F) in
HIV-1-positive patients. Collectively, although these results
are just correlative and suggestive, they support the notioner Inc.
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Figure 6. RVB2 Is Antagonized by HIV-1 Env
(A and B) Infectious clone pNLenv-luc was trans-
fected into HEK293 cells with a plasmid expressing
RVB2 (A) or an shRNA targeting RVB2 (B). A plasmid
expressing GFP was included to serve as a control.
Gag expression was detected by western blotting.
(C and D) Gag was transiently expressed from
pNL4-3luc in HEK293 cells with HIV-1 Env, with or
without RVB2 (C) or an shRNA targeting RVB2 (D).
Gag expression was detected by western blotting.
(E) Gag was transiently expressed from pNL4-3luc
in HEK293 cells with the Env CTD from NL4-3 with
or without RVB2. Gag expression was detected by
western blotting.
(F) V5-tagged NL4-3 MA was transiently coex-
pressed with myc-tagged Env CTDs indicated. The
lysates were immunoprecipitated with the antibody
to V5 and detected by western blotting.
(G) Flag-tagged NL4-3 MA was transiently coex-
pressed in HEK293 cells with myc-tagged RVB2
and the Env CTD from NL4-3 or N02. Lysates were
immunoprecipitated with anti-Flag affinity gel, and
the precipitated proteins were analyzed by western
blotting.
(H) The indicated HIV-1 virus-producing plasmids
were transfected into HEK293 cells together with
a plasmid expressing anshRNA targeting RVB2.
Gag (p55) expression levels in the producer cells
were measured by western blotting. CA levels in the
culture supernatants were measured by ELISA.
The CA level expressed from NLenv-luc in the cells
transfected with a control shRNA was set as 100.
The ELISA data presented are means ± SD of
two independent measurements, representative of
three independent experiments.
The band intensities of Gag and GFP were
measured using Image J software. The intensities of
Gag were normalized with those of GFP. The rela-
tive intensity of Gag in the control cells was set as 1.
Data presented are means ± SD of three indepen-
dent experiments. See also Figure S5.that HIV-1 exploits RVB2 for effective production of infectious
virions to minimize its premature exposure to the host immune
system.
DISCUSSION
HIV-1 replication requires the assistance of a variety of host fac-
tors (Goff, 2007). We show here that the virus makes use of the
RVB2 inhibition of Gag expression and the antagonism of the in-
hibition by Env to balance the relative Gag and Env expression
levels for efficient production of infectious virions. RVB2 plays
important roles in a variety of biological processes and is evolu-
tionarily very conserved (Parfait et al., 2000). Our observation
that RVB2 also inhibited the production of VSG-G pseudotyped
HIV-2 and SIV (Figure S3) suggests that other lentiviruses mightCell Host & Microbe 18, 233–24also use RVB2 to balance their viral protein
expressions, though further investigation
will be needed to prove this.
RVB2 promotes the degradation of gag
mRNA in a translation-dependent manner.We provided evidence implicating that RVB2 binding to nascent
MA and the 50 UTR of the translating mRNA causes ribosome
stalling and subsequent target mRNA degradation. Nascent
peptide-mediated ribosome stalling and subsequent degrada-
tion of the translating mRNA have been widely observed in
many settings. Ribosome stalling can be elicited by usage of
rare codons (Buchan and Stansfield, 2007; Lemm and Ross,
2002; Plotkin and Kudla, 2011), interference by an upstream
open reading frame (Law et al., 2001), interactions between
nascent peptide and ribosome exit tunnel components (Law-
rence et al., 2008; Nakatogawa and Ito, 2002), and heat shock
protein-dependent modulations in stress stimuli (Liu et al.,
2013). Ribosome stalling-induced mRNA decay has been re-
ported with b-tubulin (Caron et al., 1985) and CGS1 (Onouchi
et al., 2005) mRNAs and other settings in yeast (Doma and2, August 12, 2015 ª2015 Elsevier Inc. 239
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Figure 7. RVB2 Modulates HIV-1 Infectivity
at an Early Stage of Virus Production
(A–C) pNL4-3 and a plasmid expressing an shRNA
targeting RVB2 were cotransfected into HEK293T
cells. A plasmid expressing GFP was included to
serve as a control. At 12 and 24 hr posttransfection,
culture supernatants were collected and concen-
trated by centrifugation. (A and B) Viral proteins in
the cell lysates (A) or in the culture supernatants (B)
were detected by western blotting. (C) CA (p24)
levels in the culture supernatants were quantified
by ELISA. Equal amounts of CA-containing virus
were used to infect TZM-bl indicator cells. At 48 hr
postinfection, luciferase activity was measured.
Relative luciferase activity in the cells infected with
the virus produced from control shRNA-trans-
fected cells was set as 100. Data presented are
means ± SD of two independent measurements,
representative of three independent experiments.
The band intensities p55, gp160, and p24 were
measured using the Image J software. The in-
tensities of p55 and gp160 in the cell lysate were
normalized by those of GFP. The relative intensity
in the control cells was set as 1. Data presented are
means ± SD of three independent experiments.
(D–F) PBMC were collected from HIV-1-negative
controls (NC), HIV-1-positive rapid disease pro-
gressors (RP), and long-term nonprogressors
(LTNP). CD4+ T cell count, viral load (VL), and RVB2
mRNA levels were measured. See also Figure S6.Parker, 2006). Ribosome stalling serves as a signal for mRNA
surveillance (Graille and Se´raphin, 2012), as most commonly
seen in NGD (Doma and Parker, 2006). In NGD, Pelo/Hbs1L as-
sociates with the stalling ribosome and induces target mRNA
degradation (Becker et al., 2011; Graille and Se´raphin, 2012).
RVB2-mediated mRNA degradation is conceptually similar to
but mechanistically distinct from these reported processes.
RVB2 interacts with MA, and such interaction appears to facili-
tate RVB2 binding to the 50 UTR of the translating mRNA (Figures
3A and 3B). Simultaneous binding of RVB2 to nascent MA and
the 50 UTR of the translating mRNA likely causes ribosome stall-
ing on the mRNA, which leads to target mRNA degradation. This
notion is supported by our observations that RVB2 associated
with ribosomes in a reporter mRNA-dependent manner (Fig-
ure 5B) and that downregulation of Pelo almost prevented
RVB2-mediated target mRNA degradation without affecting
RVB2 inhibition of the reporter protein expression (Figures 5C–
5E). Noticeably, RVB2 association with ribosomes was detect-
able when MA-luc reporter was used, although the association
wasmuchweaker than that in the presence of the RVB2-respon-
sive reporter SLMA-luc (Figure 5B). A plausible explanation is
that RVB2 binds to the nascent MA and that this binding bridges
RVB2 to the translating ribosome. Without the 50 UTR in the re-
porter mRNA, RVB2 binding to the nascent MA did not cause
ribosome stalling.240 Cell Host & Microbe 18, 233–242, August 12, 2015 ª2015 Elsevier Inc.Compared with other retroviruses,
lentiviral envelopes have long cyto-
plasmic tails (Postler and Desrosiers,
2013; Santos da Silva et al., 2013). It is
not fully understood why such a longCTD is conserved, although multiple functions of Env CTD
have been reported (Postler and Desrosiers, 2013). While the
interaction between MA and Env CTD is thought to contribute
to the incorporation of Env into virions (Muranyi et al., 2013), en-
velopes with truncated CTD still function in some cell types (Mur-
akami and Freed, 2000). Here, we constructed a recombinant
HIV-1 virus containing the MA and Env CTD that do not interact
with each other. The chimeric virus was still viable, although its
production was considerably compromised (Figure S5). These
results indicate that the interaction between MA and Env CTD
is important but not absolutely required for virus production.
Our observation that the production of the chimeric virus was
significantly enhanced by downregulation of endogenous
RVB2 not only highlights the importance to the virus of the threat
from RVB2 but also implies a function of Env CTD in supporting
viral production.
Based on the results reported here, we propose a working
model for RVB2 inhibition of Gag expression (Figure S7). During
the translation of Gag, RVB2 binds to the nascent MA, which fa-
cilitates RVB2 binding to the 50 UTR of the translating mRNA.
Simultaneous binding of RVB2 to the 50 UTR and the nascent
peptide results in ribosome stalling, which recruits Pelo to initiate
mRNA degradation. The CTD of the viral envelope antagonizes
RVB2 by competitively preventing RVB2 interaction with MA.
This relief from RVB2 inhibition is timed during viral genome
expression to coordinate translation and packaging during virion
assembly at the plasma membrane.
EXPERIMENTAL PROCEDURES
Information about plasmids, antibodies, cell culture, virus production and
infection, and HIV-1-positive patients can be found in the Supplemental
Information.
Virus Preparation
To produce VSV-G pseudotyped HIV-1 vectors in HEK293 cells, plasmids
pNL4-3-luc and pVSV-G were transfected into the cells using Lipofectamine
2000 (Invitrogen) following the manufacturer’s instruction. To produce
VSV-G pseudotyped HIV-1 vectors in MT-4 cells, the cells were nucleofected
with the HIV-1 vector-producing plasmids using nucleofector (AMAXA)
following manufacturer’s instructions. For western blotting analyses of virion
particles, culture supernatants were loaded on a 25% sucrose cushion in
TNE buffer and centrifuged at 25,000 rpm for 2 hr at 4C, and pellets were re-
suspended in SDS-PAGE loading buffer. For ELISA assays, culture superna-
tants were collected and p24 levels were measured using HIV-Ag/Ab ELISA
kit following the manufacturer’s instruction (Wantai, Beijing, China).
Luciferase Assays
Unless otherwise indicated, for all the transfections of constructs expressing
firefly luciferase, a plasmid expressing renilla luciferase was included to serve
as a control for transfection efficiency and sample handling. Luciferase activ-
ities were measured with the Luciferase Assay System for firefly luciferase or
with the Dual-Luciferase Reporter Assay System (Promeaga). The firefly lucif-
erase activity was normalized by renilla luciferase activity.
RVB2-MA-luc Interaction Assays
The assay was adapted from a similar assay previously described (Cosson,
1996). Briefly, Flag-tagged RVB2 and MA-luc reporter were separately ex-
pressed in HEK293T cells. At 48 hr posttransfection, cells were lysed. The clar-
ified lysates were mixed and incubated with protein G beads (GE Healthcare)
and anti-Flag antibody for 8 hr. The beads were washed three times with PBS
(Hyclone), resuspended in PBS, andmeasured for firefly luciferase activity with
the Luciferase Assay System.
RNA Detection
To measure the mRNA levels, RNA was extracted with TRIzol (Invitrogen) and
treated with RNase-free DNase (Promega) to avoid plasmid DNA contamina-
tion followed by heat inactivation of the enzyme. The RNA was reverse tran-
scribed and detected by PCR. The method for detecting protein-associated
mRNA has been described previously (Xuan et al., 2013). Briefly, HeLa cells
were transfected with plasmids expressing Flag-tagged RVB2 and the lucif-
erase reporter. At 48 hr posttransfection, cells were lysed with RNase-free
passive lysis buffer (Promega). The lysates were immunoprecipitated with
anti-Flag antibody to precipitate RVB2 and associated RNA. The RNA was
extracted with TRIzol reagent, reverse transcribed, and detected by PCR.
Ribosome Pelleting Assays
The method was adapted from a protocol described previously (Shao et al.,
2013). Briefly, HeLa cells were transfected with a plasmid expressing Flag-
tagged RVB2 and luciferase reporters. At 24 hr posttransfection, cells were
lysed with RNC buffer (50 mM HEPES [pH 7.4], 100 mM KAc, 5 mM MgCl2)
supplemented with NP-40 at a final concentration of 0.1% (v/v). The lysates
were incubated on ice for 10 m before loading onto a 0.5 M sucrose cushion
in RNC buffer. The samples were centrifuged at 78,000 rpm for 90 min at
4C. The pellet was resuspended in RNC buffer and subjected to protein
and RNA detections.
Data Analysis and Presentation
The arithmetic mean values ±SD were calculated from three independent ex-
periments. The p values were calculated using the two-tailed paired Student’s
t test, and p < 0.05 was considered significant. Mann-Whitney U test was used
for comparison of RVB2 levels. Spearman rank correlations were used toCell Hosanalyze the correlation between RVB2 mRNA levels and CD4+ T cell counts
and viral loads.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article at http://dx.doi.org/10.
1016/j.chom.2015.06.018.
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